(FY)Mar 31, 2024 | (Q9)Dec 31, 2023 | (Q6)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q3)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q9)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -53.20%76.07M | -47.50%71.94M | -54.33%48.58M | -35.87%26.19M | -49.78%162.53M | -52.91%137.04M | -52.65%106.37M | -67.45%40.84M | -36.00%323.63M | -19.92%291.02M |
Operating income | -53.20%76.07M | -47.50%71.94M | -54.33%48.58M | -35.87%26.19M | -49.78%162.53M | -52.91%137.04M | -52.65%106.37M | -67.45%40.84M | -36.00%323.63M | -19.92%291.02M |
Cost of sales | 62.97%-55.21M | 58.44%-52.43M | 62.04%-37.31M | 42.60%-21.69M | 48.26%-149.08M | 47.12%-126.17M | 44.90%-98.26M | 62.46%-37.78M | 37.80%-288.14M | 27.19%-238.61M |
Operating expenses | 62.97%-55.21M | 58.44%-52.43M | 62.04%-37.31M | 42.60%-21.69M | 48.26%-149.08M | 47.12%-126.17M | 44.90%-98.26M | 62.46%-37.78M | 37.80%-288.14M | 27.19%-238.61M |
Gross profit | 55.08%20.86M | 79.47%19.51M | 39.02%11.27M | 47.45%4.5M | -62.10%13.45M | -79.26%10.87M | -82.49%8.11M | -87.69%3.05M | -16.46%35.5M | 46.89%52.41M |
Selling expenses | 13.52%-2.02M | 9.02%-1.61M | 17.57%-868K | 19.51%-392K | 55.74%-2.34M | 57.74%-1.77M | 61.23%-1.05M | 62.07%-487K | 5.07%-5.28M | 7.96%-4.2M |
Administrative expenses | 58.00%-19.4M | 49.62%-16.03M | 29.86%-11.14M | 44.89%-5M | 13.51%-46.2M | 32.87%-31.81M | 50.47%-15.88M | 23.96%-9.07M | -13.05%-53.42M | -123.19%-47.38M |
Revaluation surplus | 61.36%-4.66M | 914.13%3M | 277.91%3M | -69.56%1.04M | -188.73%-12.07M | ---368K | 76.06%-1.68M | 1,007.16%3.42M | 49.01%-4.18M | ---- |
-Changes in the fair value of investment property | 57.33%-4.11M | ---- | ---- | ---- | -7,853.72%-9.62M | ---- | ---- | ---- | -105.73%-121K | ---- |
-Changes in the fair value of other assets | 77.26%-556K | 914.13%3M | 277.91%3M | -69.56%1.04M | 39.76%-2.45M | ---368K | 76.06%-1.68M | 1,007.16%3.42M | 60.63%-4.06M | ---- |
Impairment and provision | 71.44%-6.46M | ---- | ---- | ---- | -12.94%-22.62M | ---- | ---- | ---- | -107.89%-20.02M | ---- |
-Impairment of property, machinery and equipment | 39.97%-9.38M | ---- | ---- | ---- | ---15.63M | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | 141.90%2.93M | ---- | ---- | ---- | 65.13%-6.98M | ---- | ---- | ---- | -107.89%-20.02M | ---- |
Special items of operating profit | 388.59%2.74M | -101.07%-1.69M | -8,441.18%-2.9M | -17.65%-2.65M | 148.45%561K | 94.17%-840K | 99.62%-34K | 78.03%-2.26M | -163.45%-1.16M | -4.64%-14.4M |
Operating profit | 87.08%-8.94M | 113.29%3.18M | 93.95%-638K | 53.16%-2.5M | -42.51%-69.21M | -76.24%-23.92M | -135.43%-10.54M | -659.16%-5.34M | -84.45%-48.56M | -250.49%-13.57M |
Financing cost | -16.93%-297K | -9.60%-217K | 2.24%-131K | 25.71%-52K | 63.35%-254K | 76.12%-198K | 65.46%-134K | -141.38%-70K | 38.07%-693K | 15.92%-829K |
Earning before tax | 86.70%-9.24M | 112.28%2.96M | 92.79%-769K | 52.81%-2.55M | -41.02%-69.46M | -67.47%-24.12M | -119.41%-10.67M | -684.23%-5.41M | -79.46%-49.26M | -196.42%-14.4M |
Tax | -56.64%1.05M | 658.14%326K | 1,361.90%307K | -90.04%25K | 1,699.34%2.43M | -6.52%43K | -41.67%21K | 727.50%251K | 71.21%-152K | 103.07%46K |
After-tax profit from continuing operations | 87.79%-8.19M | 113.65%3.29M | 95.66%-462K | 51.00%-2.53M | -35.66%-67.03M | -67.71%-24.07M | -120.61%-10.65M | -682.28%-5.16M | -76.61%-49.41M | -125.76%-14.35M |
Earning after tax | 87.79%-8.19M | 113.65%3.29M | 95.66%-462K | 51.00%-2.53M | -35.66%-67.03M | -67.71%-24.07M | -120.61%-10.65M | -682.28%-5.16M | -76.61%-49.41M | -125.76%-14.35M |
Minority profit | 110.99%974K | -51.28%3.36M | -33.76%1.91M | 195.96%475K | -6.47%-8.87M | 5,850.83%6.9M | -22.56%2.88M | -109.31%-495K | -41.69%-8.33M | -103.59%-120K |
Profit attributable to shareholders | 84.25%-9.16M | 99.76%-75K | 82.50%-2.37M | 35.61%-3M | -41.58%-58.16M | -117.61%-30.97M | -58.36%-13.53M | -5.23%-4.66M | -85.90%-41.08M | -46.74%-14.23M |
Basic earnings per share | 84.27%-0.0277 | 82.44%-0.0072 | 35.46%-0.0091 | -41.33%-0.1761 | -57.69%-0.041 | -4.44%-0.0141 | -80.58%-0.1246 | -41.64%-0.0432 | ||
Diluted earnings per share | 84.27%-0.0277 | 82.44%-0.0072 | 35.46%-0.0091 | -41.33%-0.1761 | -57.69%-0.041 | -4.44%-0.0141 | -80.58%-0.1246 | -41.64%-0.0432 | ||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | -- | -- | -- | -- | National Health Certified Public Accountants Limited | -- | -- | -- | National Health Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data